The Economist asks:

Will the Chinese government publicly announce that it has approved the use of a foreign mRNA COVID-19 vaccine for use among its citizens in the People's Republic of China (PRC) before 2 May 2023?

Started Dec 02, 2022 06:00PM UTC
Closed May 02, 2023 07:01AM UTC

While China in November 2022 agreed to allow German expatriates in the country to receive Pfizer/BioNTech COVID-19 vaccines, China has yet to approve more effective foreign mRNA COVID-19 vaccines for use among Chinese citizens (Economist, Politico, NPR, ABC News, Track Vaccines, JHU Bloomberg School of Public Health). An approval does not need to include every Chinese citizen to count, but approvals for research and/or trials alone would not count.

Confused? Check our FAQ or ask us for help. To learn more about Good Judgment and Superforecasting, click here.

To learn more about how you can become a Superforecaster, see hereFor other posts from our Insights blog, click here.

NOTE 22 December 2022: China approving the use of a foreign-developed vaccine manufactured in China would count. China approving the use of a vaccine developed in a partnership between Chinese and foreign firms would not count.

The question closed "No" with a closing date of 2 May 2023.

See our FAQ to learn about how we resolve questions and how scores are calculated.

Possible Answer Correct? Final Crowd Forecast
Yes 6.36%
No 93.64%

Crowd Forecast Profile

Participation Level
Number of Forecasters 338
Average for questions older than 6 months: 230
Number of Forecasts 812
Average for questions older than 6 months: 638
Participants in this question vs. all forecasters average

Most Accurate

Relative Brier Score


Recent Consensus, Probability Over Time

Tip: Mention someone by typing @username